|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses – current | ||||||||||||||||||||
| Held-to-maturity investment securities | ||||||||||||||||||||
| Trade and other receivables, net of allowance | ||||||||||||||||||||
| Contract assets, net of allowance | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Non-current held-to-maturity investment securities | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| Equity security investment | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Mezzanine Equity and Shareholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| AM SAFE liability | ||||||||||||||||||||
| Warrants | ||||||||||||||||||||
| Warrants | ||||||||||||||||||||
| PIPE Warrant | ||||||||||||||||||||
| Total warrants | ||||||||||||||||||||
| Fixed Maturity Consideration and current FPA Put Option liability | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Accrued salaries and wages | ||||||||||||||||||||
| Current lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current lease liabilities | ||||||||||||||||||||
| Non-current contract liabilities | ||||||||||||||||||||
| Fixed Maturity Consideration | ||||||||||||||||||||
| FPA Put Option liability | ||||||||||||||||||||
| Brookfield SAFE liability | ||||||||||||||||||||
| Brookfield Loan liability | ||||||||||||||||||||
| Convertible Note | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine Equity | ||||||||||||||||||||
| Convertible preferred stock, $0.0001 par value; 20,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 0 and 20,000,000 shares issued as of June 30, 2026 and December 31, 2025, respectively; and 0 and 20,000,000 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Preferred stock - additional paid-in capital | ||||||||||||||||||||
| Total mezzanine equity | ||||||||||||||||||||
| Shareholders’ Equity/(Deficit) | ||||||||||||||||||||
| Common stock, $0.0000001 par value, 25,800,000 shares authorized as of June 30, 2026 and December 31, 2025; 13,089,163 and 2,320,511 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total common stock, $0.0000001 par value, 25,800,000 shares authorized as of June 30, 2026 and December 31, 2025; 13,089,163 and 2,320,511 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ equity/(deficit) | ||||||||||||||||||||
| Total liabilities, mezzanine equity and shareholders' equity | ||||||||||||||||||||
| Temporary equity, shares outstanding (in shares) | ||||||||||||||||||||
| Total temporary equity, shares outstanding (in shares) | ||||||||||||||||||||
Loading...